Objective To establish a surveillance network for cardiovascular diseases (CVD) risk factors in industrial settings and estimate the risk factor burden using standardized tools. Methods We conducted a baseline cross-sectional survey (as part of a CVD surveillance programme) of industrial populations from 10 companies across India, situated in close proximity to medical colleges that served as study centres. The study subjects were employees (selected by age and sex stratified random sampling) and their family members. Information on behavioural, clinical and biochemical determinants was obtained through standardized methods (questionnaires, clinical measurements and biochemical analysis). Data collation and analyses were done at the national coordinating centre. Findings We report the prevalence of CVD risk factors among individuals aged 20-69 years (n = 19 973 for the questionnaire survey, n = 10 442 for biochemical investigations); mean age was 40 years. The overall prevalence of most risk factors was high, with 50.9% of men and 51.9% of women being overweight, central obesity was observed among 30.9% of men and 32.8% of women, and 40.2% of men and 14.9% of women reported current tobacco use. Self-reported prevalence of diabetes (5.3%) and hypertension (10.9%) was lower than when measured clinically and biochemically (10.1% and 27.7%, respectively). There was marked heterogeneity in the prevalence of risk factors among the study centres. Conclusion There is a high burden of CVD risk factors among industrial populations across India. The surveillance system can be used as a model for replication in India as well as other developing countries. Voir page 467 le résumé en français. En la página 468 figura un resumen en español.
Introduction
Cardiovascular diseases (CVDs are maj j jor contributors to the global burden of chronic diseases with 29.3% of global deaths and 9.9% of total disease burden, in terms of disabilityjadjusted life years (DALYs) lost, being reported in 2003. 1 Lowj and middlejincome countries acj j counted for 78% and 86% of the CVD deaths and DALYs lost, respectively, worldwide in 1998. 2 Recent estimates by WHO suggest that in 2005, 80% of chronic disease deaths occurred in lowj and middlejincome countries. 3 This burden of CVD is predicted to increase substantially in developing countries by a Department of Cardiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. Correspondence to Dr Reddy (email: ksreddy@ccdcindia.org 4 Major causes for the inj j crease in disease burden are rising rates of hypertension, dyslipidaemia, diabetes, overweight, obesity, physical inactivity and tobacco use. 5 In India, CVD is projected to be the largest cause of death and disabilj j ity by 2020, 5 with 2.6 million Indians predicted to die due to coronary heart disease, which constitutes 54.1% of all CVD deaths. Nearly half of these deaths are likely to occur among young and middlejaged individuals (30-69 years) . This is because Indians experience CVD deaths at least a decade earlier than their counterparts in developed countries. 6 This has the potential to adversely affect India's economy with 52% of CVD deaths occurring in those below the age of 70 years compared to 23% in countries in established market economies. 4 Demographic and health transij j tions, genejenvironmental interactions and early life influences of fetal malnuj j trition have been implicated as the causes of increasing CVD burden in India. 7 However, the most important factors are changes in living habits, whereby behavioural risk factors are transformed into biological risk factors. Such envij j ronmentallyjdetermined risk factors are more amenable to change through public health and clinical interventions and, therefore, warrant early recognition at the individual level and surveillance at the population level.
To formulate national policies for the prevention and control of CVDs, nationally representative data collected through standardized techniques would be required. However, published crossj sectional studies on risk factors, such as hypertension, [8] [9] [10] [11] diabetes, 11-14 impaired fasting glucose, 14 dyslipidaemia, 15 overj j weight, [16] [17] [18] [19] obesity, 18, 20 and smoking, [21] [22] [23] are highly heterogeneous and limited by variations in measurement techniques, interviewer bias, and differing definij j tions for risk factors and time periods of survey. We designed and established a sentinel surveillance system for CVD risk factors in Indian industrial populaj j tions with the following objectives:
• to conduct a baseline survey and continual surveillance of CVD risk factors and their determinants; • to ascertain the incidence of CVD morbidity and mortality; • to impart health education for prej j vention of CVD and assess the imj j pact of health education on control of CVD; • to develop guidelines for detection and management of CVD in the inj j dustrial settings, using the results of the baseline study.
We report the methods and results of the baseline survey conducted in 2002-03, in accordance with the first objective.
Methods

Study setting
We selected 10 mediumjtojlarge comj j panies (employing 1500-5000 people) in the organized sector (both public and private), from different sites across India, based on their willingness to participate in the study and proximity to an acaj j demic medical institution. Ten medical colleges designated as study centres were linked to each of these selected compaj j nies ( 
Study variables
We collected data on demographics, inj j dividual characteristics associated with major risk factors of CVD, past medij j cal history, clinical and anthropometric profile and biochemical parameters (Table 2 ).
Quality control measures
To ensure the accuracy, completeness, as well as comparability of blood presj j sure, anthropometric measurements, and interviewee responses across the The current primary occupation was the employment status of the individual. c Physical activity level assessed using close-ended questions probing the self-perceived, self-reported type (occupational, domestic, leisure time and transport related) and intensity of physical activity, was classified as "very light" (walking, job involving desk work, watching television), "light" (standing all day working, housework such as cooking, cleaning in the house), "moderate physical activity" (gardening, agricultural work, walking long distances up and down hills, climbing more than 20 steps in a day), and "heavy" (lifting heavy weights, construction work, manual labour, and running). d CVD = cardiovascular disease. e Either a systolic blood pressure >140 mmHg, and/or a diastolic blood pressure >90 mmHg, and/or on drug treatment for hypertension. 24 f Either fasting blood glucose value >126 mg/dl 25 and/or on medication for diabetes. Impaired fasting glucose (IFG) was a fasting blood glucose value >110 to <126 mg/dl. g HDL = high density lipoprotein.
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Surveillance system for cardiovascular diseases in India 10 centres, we included several quality control measures in the study protoj j col. We developed a common manual of operations and distributed it to all participating centres. To ensure uniforj j mity of data collection we conducted nationaljlevel questionnaire administraj j tion training sessions for all study staff. We pilotjtested all questions for clarity and "face validity" ("Does the question refer to what it intends to seek?") and developed the standard final version of the questionnaire and distributed to all centres.
Pilot study
We conducted a pilot study using 10-25 individuals in May-June 2001, in all the centres, to evaluate the measurej j ment tools, feasibility of transporting blood samples for biochemical analysis, efficiency of data transfer and qualj j ity assessment of transferred data. We modified the study protocol and survey instruments based on results from the pilot study. Those who were part of the pilot study were excluded from the main study.
Questionnaire administration and measurement techniques
We obtained written informed consent from the 19 973 individuals who rej j sponded to the questionnaire survey. We estimated fasting blood glucose and fastj j ing lipid profile in 10 442 individuals. Blood was collected after an overnight fast of 10-12 hours. Blood pressure (BP) was measured using automated BP monitoring equipment (Omron MX3) according to the procedure detailed in the instruction manual. Waist circumj j ference (WC) was measured with a standard tape measure, while subjects were lightly clothed, at a level midway between the lower rib margin and iliac crest in centimetres (cm) to the nearest 0.1 cm. Weight was taken (to the nearj j est 0.1 kg) with the subject standing motionless on an electronic weighing machine without shoes or any heavy outer garments, and weight equally distributed over each leg. Height was measured (to the nearest 0.1 cm) using a standard stadiometer with the subject standing erect against a vertical surface, without shoes, and the head positioned such that top of the external auditory meatus was level with the inferior margin of the bony orbit.
Laboratory techniques and biochemical standardization
The Department of Cardiac Biochemisj j try at the All India Institute of Medical Sciences (AIIMS), New Delhi was rej j sponsible for biochemical standardizaj j tion at each centre and coordination. We estimated glucose by GODjPAP (glucose oxidase/peroxidasej4jaminophenazonej phenol; Randox) method, cholesterol by CHODjPAP (cholesterol oxidase/ pjaminophenazone; Randox) method, and triglycerides by GPOjPAP (glycerj j olphosphate oxidase-peroxidase amij j nophenazone; Randox) method. Highj density lipoprotein (HDL) was estimated by the precipitation method using phosj j photungstate/magnesium -precipitaj j tion of apolipoprotein B containing lipoproteins followed by estimation of cholesterol in the supernatant by enzyj j matic method. All estimation kits and quality control materials were sent from the coordinating laboratory to the centre to minimize variation. We regularly performed both interj j nal and external quality assessments at all participating laboratories along with validity checks to ensure accurate and consistent results. For quality assurance, we conducted different levels of internal quality controls with each batch of samples. The interj and intrajassay coefj j ficient of variation of each individual laboratory was less than 2% and 3%, respectively, for glucose and cholesterol estimations, and less than 2.5% and 3.5%, respectively, for triglycerides and HDLjcholesterol (HDLjc) estimaj j tions. For external validation, we sent lyophilized samples from the coordinatj j ing laboratory once a month to all parj j ticipating laboratories throughout the period of the study. We also rejanalysed 10% of samples selected randomly from all centres in the coordinating laboraj j tory as an additional quality assurance measure. The coefficient of variation was less than 5% for all, except for HDLjc at Bangalore (this was rejanalysed at the coordinating centre).
Findings
Based on our proposed sampling scheme we approached 22 266 individuals. However, only 19 973 consented to parj j ticipate in the study, yielding a response rate of 89.7%. The response rates varied across centres. The distribution of the study population is provided in Table 3 . The general characteristics of the study population are given in Table 4 (web verj j sion only, available from: http://www. who.int/bulletin).
Demographic characteristics
The mean age of the participants in our study was 40 years (range of mean age: 32 years at Nagpur to 45.4 years at Delhi), with only 5% in >60 age group. More than threejquarters of the subjects (77.7%) had at least secondary school education while 12.1% were illiterate. A third (34%) of the study population comprised both unemployed or retired individuals (10%) and homejmakers (24%). We observed a wide variation in educational status and occupation across all centres.
Behavioural determinants
Our results showed that onejthird (33.6%) of the subjects had history of tobacco use in any form and 30% were using tobacco regularly. Smoking was the major form of tobacco use (12.6%), followed by use as snuff (10.7%), and tobacco chewing (9%). Current smoking and chewing prevalence rates were signifj j
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icantly higher among men (21% versus 0.2% and 13.3% versus 2.6%) whereas tobacco use as snuff was higher among women (9.5% versus 12.4%). Of our study subjects 12% took alcohol regularj j ly and 12.5% took alcohol occasionally. A large number of our study participants (51.4%) reported medium level of physij j cal activity, 3.4% reported very light physical activity, while 13% reported high physical activity level.
Anthropometric measurements
Our results showed a mean body mass index (BMI) of 23.1 kg/m² (95% conj j fidence interval (95% CI) = 14. Women had a higher prevalence of central obesity compared to men, across all age groups. The agej and sexjspecific mean levels of BP, BMI, WC, and lipid levels as continuous variables are given in Table 5 and the agej and sexjspecific prevalence of elevated risk factors as categorical varij j ables are provided in Table 6 .
Clinical and biochemical measurements Blood pressure
Mean systolic blood pressure (SBP) was 125.4 mmHg (127.0 mmHg in men, 123.1 mmHg in women) and mean diastolic blood pressure (DBP) was 78.8 mmHg (79.2 mmHg in men, 78.1 mmHg in women). Both mean SBP and DBP increased with age among men and women. The SBP levels among men were significantly higher than those among agejmatched women until the age of 49 years, after which the levels were higher among women. Selfjreported prevalence of hypertension was 10.9% and the prevalence of hypertension and "prej hypertension" ("Blood pressure between 120/80 mmHg and 139/89 mmHg."), by JNC VII criteria was 27.7%, and 56.3%, respectively. The prevalence of hypertension and prejhypertension inj j creased with age.
Lipids
Mean total cholesterol and mean HDL cholesterol were 176.6 mg/dl (177.1 mg/dl in men, 175.7 mg/dl in women) and 42.3 mg/dl (41.5 mg/dl in men, 44.6 mg/dl in women), respectively.
Mean total cholesterol increased with age, whereas HDL cholesterol had no linear relationship with age. The mean total cholesterol-HDL cholesterol ratio (TC/HDLjc) was 4.3 (4.4 in men, 4.1 in women). Women had lower TC/HDLjc compared to men across all age groups. Dyslipidaemia prevalence (TC/HDL >4.5 or triglycerides >150 mg/dl) showed a linear increase with age, until the age of 50 years. Dyslipidaemia in the age group 50-59 years (for both men and women) did not differ from that in the previous age group; however, it was lower in the age group of 60-69 years, than in the previous age groups. 26 NCEP ATP III guidelines define metabolic syndrome based on presence of any three of the following five components: abdominal obesity, elevated triglycerides, low HDL cholesterol, raised blood pressure and impaired fasting glucose levels. syndrome, 46.7% for BMI >23 kg/m², 25.5% among men and 30.3% among women for central obesity (WC >90 cm in men, WC >85 cm in women), 37.5% for dyslipidaemia (TC/HDL >4.5) and 24.3% for hyperjtriglyceridaemia (trij j glycerides >150 mg/dl) (Fig. 1) .
Diabetes and metabolic syndrome
Heterogeneity in risk factors among participating centres
Our results showed widejranging hetj j erogeneity among risk factor prevalence across the different centres ( 
Discussion
In the absence of a populationjbased nationally representative surveillance system for CVD, establishing a multij centric surveillance system in industrial settings could be a useful initial step, the first component being a baseline crossj sectional survey of risk factors.
In our baseline crossjsectional surj j vey the choice of industrial settings was based on the availability of functioning healthjcare services in those industries and the assurance of good followjup. The additional costs of CVD surveilj j lance under such circumstances are low with high quality information yield. The inclusion of family members allowed us to study people in the age groups of 10-19 years and 60-69 years as well as a large number of women to balance the predominantly male employee group.
We observed a high prevalence of CVD risk factors among a relatively young population across the selected industrial populations. Our results are consistent with high prevalence of CVD risk factors reported in previous crossj sectional studies conducted at various geographical locations in India. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] If we project our findings to the whole industrial population of India the magj j nitude of the number of persons living with CVD risk factors, such as tobacco use, overweight, hypertension, diabetes, and metabolic syndrome would pose a major challenge to the existing healthj care systems.
Our results showed marked heteroj j geneity in the prevalence of risk factors across the centres. This may be due to dissimilar levels of urbanization in the different industrial settings as some are located in a rural/semi rural situaj j tion while others are in more urbanized regions. For example, the prevalence of diabetes was low in the predominantly rural setting of Dibrugarh and Nagpur.
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Overweight = body mass index (BMI) ‡23 kg/m 2 , which is the suggested cut-off for Asians. 28, 29 Central obesity = waist circumference >90 cm in males; >85 cm in females. Dyslipidaemia = total cholesterol/HDL-cholesterol ratio. Hypertriglyceridemia = fasting triglyceride level ‡150 mg/dl. Diabetes = fasting plasma glucose ‡126 mg/dl or on treatment. Hypertension = systolic blood pressure ‡140 mmHg or diastolic blood pressure ‡90 mmHg or on treatment. Tobacco use = current use of tobacco in any form. Metabolic syndrome, based on NCEP ATP III criteria. The only exception was the high prevaj j lence of hypertension among the tea garden workers of Dibrugarh, which could be attributable to the practice by employees of adding salt to drinking waj j ter and tea while working in the field. Wide variability in the measurej j ments of lipids, specifically triglycerides and HDLjc, are well known and stanj j dardizing these measurements is particuj j larly difficult. 30 Our biochemical quality control strategies were a unique feature of this study. Through simple measures of maintaining internal validity of the participating laboratories and ensuring external validity by assessment of blinded lyophilized samples we were able to esj j tablish a high degree of quality in the 10 participating laboratories.
One of the limitations of our study was the industrial setting, which may not be representative and applicable to the general population. The participants in our sentinel surveillance system formed a stable surrogate community for surj j veillance unlike the general population where loss to followjup is frequent and continuous monitoring of risk factors more expensive. Though the inclusion of family members of employees in the reference population should have imj j proved the generalization of the results, the age structure and socioeconomic status of the industrial populations are different from that of the general popuj j lation. The results of our study cannot be generalized to those >60 years of age, as the numbers in this age group, especially women, were small in our sample compared to other age groups. Further, the sustainability of the system depends on the continuing interest of the participating companies.
The high levels of risk observed with our baseline crossjsectional survey justifies the need for establishing a surj j veillance system to monitor the trends of CVD risk factors over time and has persuaded the participating industries to accept the proposed system of periodic rejsurveys of CVD risk factors as well as of continual tracking of CVDjrelated events. It also enabled us to initiate workj site programmes for health promotion and CVD reduction. We are continuing surveillance activities in seven of the 10 selected industrial settings, which includes physical and biochemical meaj j sures of major risk factors, periodic estimates of validity of the data collected and a broader set of outcome indicators beyond risk factor prevalence. A health education intervention package that was developed is being implemented in all industrial settings, and would help the target community to change risky bej j haviours to healthy behaviours. It would also enable us to demonstrate the effecj j tiveness of the health intervention packj j age in terms of change in knowledge, attitude and risk factor prevalence levels in the target community. In an effort to assess the trends in CVD mortality and morbidity an event registry, initiated at all selected industrial centres successfully from May 2003, would help us estimate the incidence of CVD mortality and morbidity in the selected populations.
Conclusions
Our study has demonstrated very high levels of CVD risk factors among a relatively young population from 10 industrial settings across India. The surveillance network established by this project is the first of its kind for CVD risk factors in India and can be used as a model for replication of prevention strategies for CVD and other noncomj j municable diseases in India as well as other developing countries. The dissemij j nation of these findings may encourage other companies to set up surveillance activities especially in developing counj j tries where the organized work force comprises a substantial number of indij j viduals. Continuing surveillance efforts would provide us with an opportunity to develop evidencejbased costjeffective CVD prevention, detection and manj j agement strategies. O Objetivo Establecer una red de vigilancia de los factores de riesgo de enfermedades cardiovasculares (ECV) en entornos industriales y estimar la carga de factores de riesgo utilizando instrumentos normalizados. Métodos Llevamos a cabo una encuesta transversal basal (como parte de un programa de vigilancia de las ECV) de las poblaciones industriales de 10 empresas de la India, situadas muy cerca de las escuelas de medicina empleadas como centros de estudio. Los sujetos estudiados eran empleados de esas empresas (seleccionados mediante muestreo aleatorio estratificado por edad y sexo) y sus familiares, y la información referente a los determinantes comportamentales, clínicos y bioquímicos se obtuvo mediante métodos normalizados (cuestionarios, variables clínicas y análisis bioquímicos). La recopilación y el análisis de los datos se hicieron en el centro coordinador nacional. Resultados Notificamos aquí la prevalencia de los factores de riesgo de ECV entre los individuos de 20 a 69 años (n = 19 973 para la encuesta mediante cuestionario, n = 10 442 para los análisis bioquímicos), con una edad media de 40 años. La prevalencia general de la mayoría de los factores de riesgo fue alta: exceso de peso en el 50,9% de los hombres y el 51,9% de las mujeres, obesidad central en el 30,9% de los hombres y el 32,8% de las mujeres, y consumo de tabaco en el 40,2% de los hombres y el 14,9% de las mujeres. La prevalencia autonotificada de diabetes (5,3%) e hipertensión (10,9%) fue menor que la determinada clínica y bioquímicamente (10,1% y 27,7%, respectivamente). Se observó una notable heterogeneidad en la prevalencia de factores de riesgo entre los centros de estudio. Conclusión Existe una alta carga de factores de riesgo de ECV entre las poblaciones industriales en la India. El sistema de vigilancia puede servir de modelo para repetir la experiencia en este país y en otros países en desarrollo.
